Close Menu

NEW YORK – The GenomeWeb Index fell 4 percent in August, despite a continued rise in the broader markets and what had been several months of gains for shares of firms in the omics tools and molecular diagnostics sectors.

The index underperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which rose nearly 8 percent, nearly 10 percent, and nearly 1 percent, respectively. Individual stock performances in the GenomeWeb Index were mixed in August, as 19 of the 32 stocks saw gains and 13 saw losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.